Dopamine D3 and D4 Receptor Antagonists: Synthesis and Structure−Activity Relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl)amino]-2-methoxybenzamide (YM-43611) and Related Compounds
Authors:
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (14) , 2764-2772
Abstract
In this study, we synthesized a series of (S)-N-(3-pyrrolidinyl)benzamide derivatives, 1, 2a−d, 5a−l, and 7, and their enantiomers, (R)-1 and (R)-5c−e, and evaluated their binding affinity for cloned dopamine D2, D3, and D4 receptors and their inhibitory activity against apomorphine-induced climbing behavior in mice. The results indicate that D2, D3, and D4 receptors have different bulk tolerance (D4 > D3 > D2) for the substituent of the 4-amino group (R 1) on the benzamide nuclei and that cyclopropyl-, cyclobutyl-, and cyclopentylcarbonyl groups likely possess adequate bulkiness with respect to D3 and D4 affinity and selectivity over D2 receptors in this series. The results also suggested that the N-substituent (R 2) on the pyrrolidin-3-yl group performs an important role in expressing affinity for D2, D3, and D4 receptors and selectivity among the respective subtypes. One of the compounds, (S)-(+)-N-(1-benzyl-3-pyrrolidinyl)-5-chloro-4-[(cyclopropylcarbonyl)amino]-2-methoxybenzamide (5c) (YM-43611), showed high affinity for D3 and D4 receptors (Ki values of 21 and 2.1 nM, respectively) with 110-fold D4 selectivity and 10-fold D3 preference over D2 receptors and weak or negligible affinity for representative neurotransmitter receptors. Compound 5c displayed potent antipsychotic activity in inhibiting apomorphine-induced climbing behavior in mice (ED50 value, 0.32 mg/kg sc).Keywords
This publication has 20 references indexed in Scilit:
- Functional relevance of dopamine receptors Further studies are required to determine the physiological role and therapeutic significance of dopamine D3 receptorsTrends in Pharmacological Sciences, 1995
- ClozapineCNS Drugs, 1995
- Novel dopamine receptors half a decade laterTrends in Pharmacological Sciences, 1995
- Heating Up Some SQUIDsScience, 1994
- IMPROVED SYNTHESIS OF DIMETHYLAMINOTHIOACETAMIDEOrganic Preparations and Procedures International, 1992
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Optically active benzamides as predictive tools for mapping the dopamine D2 receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Molecular pathology of schizophrenia: more than one disease process?BMJ, 1980
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976
- Diphenylphosphoryl azide. New convenient reagent for a modified Curtius reaction and for peptide synthesisJournal of the American Chemical Society, 1972